77 related articles for article (PubMed ID: 24772947)
1. Effect of near field ultrasound on carboplatin treatment of ovarian carcinoma cells.
Bernard V; Mornstein V; Bourek A
Indian J Biochem Biophys; 2013 Aug; 50(4):284-8. PubMed ID: 24772947
[TBL] [Abstract][Full Text] [Related]
2. Biological effects of combined ultrasound and cisplatin treatment on ovarian carcinoma cells.
Bernard V; Skorpíková J; Mornstein V; Slaninová I
Ultrasonics; 2010 Mar; 50(3):357-62. PubMed ID: 19740505
[TBL] [Abstract][Full Text] [Related]
3. Determination of free cisplatin in medium by differential pulse polarography after ultrasound and cisplatin treatment of a cancer cell culture.
Bernard V; Fojt L; Skorpíková J; Mornstein V
Indian J Biochem Biophys; 2011 Feb; 48(1):59-62. PubMed ID: 21469604
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound and cisplatin combined treatment of human melanoma cells A375--the study of sonodynamic therapy.
Bernard V; Mornstein V; Škorpíková J; Jaroš J
Ultrasound Med Biol; 2012 Jul; 38(7):1205-11. PubMed ID: 22502893
[TBL] [Abstract][Full Text] [Related]
5. The combined effect of ultrasound exposure and cisplatin on human ovarian carcinoma cells A2780.
Bernard V; Skorpíková J; Mornstein V
Folia Biol (Praha); 2008; 54(3):97-101. PubMed ID: 18647549
[TBL] [Abstract][Full Text] [Related]
6. Akt inhibitor enhances apoptotic effect of carboplatin on human epithelial ovarian carcinoma cell lines.
Lee CS; Kim YJ; Jang ER; Myung SC; Kim W
Eur J Pharmacol; 2010 Apr; 632(1-3):7-13. PubMed ID: 20096282
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study.
Muller M; Chérel M; Dupré PF; Gouard S; Collet M; Classe JM
Eur Surg Res; 2011; 46(3):139-47. PubMed ID: 21372578
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line.
Murray TG; Cicciarelli N; McCabe CM; Ksander B; Feuer W; Schiffman J; Mieler WF; O'Brien JM
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2516-22. PubMed ID: 9375570
[TBL] [Abstract][Full Text] [Related]
10. Modulation of intrinsic in vitro resistance to carboplatin by edatrexate in the A549 human nonsmall cell lung cancer cell line.
Perez EA; Hack FM; Fletcher TS; Chou TC
Oncol Res; 1994; 6(3):151-6. PubMed ID: 7994086
[TBL] [Abstract][Full Text] [Related]
11. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.
Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H
Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368
[TBL] [Abstract][Full Text] [Related]
12. The interaction between a drug and ultrasound in sonochemotherapy against ovarian cancers.
He H; Yu T; Zhang Y
Ultraschall Med; 2012 Jun; 33(3):275-82. PubMed ID: 21165815
[TBL] [Abstract][Full Text] [Related]
13. The use of models in "target" theory to evaluate the survival curves of human ovarian carcinoma cell line exposure to adriamycin combined with ultrasound.
Yu T; Xiong Z; Chen S; Tu G
Ultrason Sonochem; 2005 Apr; 12(5):345-8. PubMed ID: 15590307
[TBL] [Abstract][Full Text] [Related]
14. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
[TBL] [Abstract][Full Text] [Related]
15. Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells.
Erices R; Bravo ML; Gonzalez P; Oliva B; Racordon D; Garrido M; Ibañez C; Kato S; Brañes J; Pizarro J; Barriga MI; Barra A; Bravo E; Alonso C; Bustamente E; Cuello MA; Owen GI
Reprod Sci; 2013 Dec; 20(12):1433-46. PubMed ID: 23653391
[TBL] [Abstract][Full Text] [Related]
16. [Cytokinetic effects of carboplatin and cisplatin on a human ovarian cancer cell line].
Yoshizumi N; Fujiwara J; Yoshizaki A; Sato M; Sakai R; Nishiya I
Hum Cell; 1988 Sep; 1(3):301-7. PubMed ID: 2979207
[TBL] [Abstract][Full Text] [Related]
17. Electrochemical monitoring of anticancer compounds on the human ovarian carcinoma cell line A2780 and its adriamycin- and Cisplatin-resistant variants.
Woolley DE; Tetlow LC; Adlam DJ; Gearey D; Eden RD; Ward TH; Allen TD
Exp Cell Res; 2002 Feb; 273(1):65-72. PubMed ID: 11795947
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
[TBL] [Abstract][Full Text] [Related]
19. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
[TBL] [Abstract][Full Text] [Related]
20. Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis.
Li Y; Hu W; Shen DY; Kavanagh JJ; Fu S
Am J Obstet Gynecol; 2009 Feb; 200(2):177.e1-9. PubMed ID: 19110234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
